OC-31 Low rates of SVR to peg-interferon plus ribavirin in HCV genotype 1 IL28B rs12979860 CC cirrhotic patients without rapid virological response

Digestive and Liver Disease ◽

10.1016/s1590-8658(12)60032-2 ◽

2012 ◽

Vol 44 ◽

pp. S11

Author(s):

E. Degasperi ◽

A. Aghemo ◽

E. Galmozzi ◽

L. Valenti ◽

S. De Nicola ◽

...

Keyword(s):

Virological Response ◽

Rapid Virological Response ◽

Hcv Genotype ◽

Cirrhotic Patients ◽

Download Full-text

1080 LOW RATES OF SVR TO PEGINTERFERON PLUS RIBAVIRIN IN HCV GENOTYPE 1 IL28B RS12979860 CC CIRRHOTIC PATIENTS WITHOUT RAPID VIROLOGICAL RESPONSE

Journal of Hepatology ◽

10.1016/s0168-8278(12)61092-7 ◽

2012 ◽

Vol 56 ◽

pp. S425

Author(s):

E. Degasperi ◽

A. Aghemo ◽

E. Galmozzi ◽

L. Valenti ◽

M.G. Rumi ◽

...

Keyword(s):

Virological Response ◽

Rapid Virological Response ◽

Hcv Genotype ◽

Cirrhotic Patients ◽

Download Full-text

Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1

Journal of Medical Virology ◽

10.1002/jmv.23323 ◽

2012 ◽

Vol 84 (8) ◽

pp. 1208-1216 ◽

Author(s):

Ahmad Amanzada ◽

Simon Schneider ◽

Federico Moriconi ◽

Alexander Lindhorst ◽

Thomas Suermann ◽

...

Keyword(s):

Treatment Outcome ◽

Combination Therapy ◽

Virological Response ◽

Rapid Virological Response ◽

Il28b Genotype ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Predictive Efficiency

Download Full-text

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

Therapeutics and Clinical Risk Management ◽

10.2147/tcrm.s124663 ◽

2017 ◽

Vol Volume 13 ◽

pp. 59-64 ◽

Author(s):

Helena Borba ◽

Astrid Wiens ◽

Laiza Steimbach ◽

Fernanda Tonin ◽

Maria Pedroso ◽

...

Keyword(s):

Longitudinal Study ◽

Virological Response ◽

Rapid Virological Response ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Brazilian Cohort

Download Full-text

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials

Journal of Virus Eradication ◽

10.1016/s2055-6640(20)30043-1 ◽

2019 ◽

Vol 5 (3) ◽

pp. 138-144

Author(s):

Kimberly Struble ◽

Kirk Chan-Tack ◽

Karen Qi ◽

Thamban Valappil ◽

Sarah Connelly ◽

...

Keyword(s):

Clinical Trials ◽

Sustained Virological Response ◽

Virological Response ◽

Response Rates ◽

Direct Acting Antivirals ◽

Systematic Analysis ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Download Full-text

828 TREATMENT WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN OLDER HCV GENOTYPE 1 PATIENTS WITH POSITIVE PROGNOSTIC FACTORS LEADS TO HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE

Journal of Hepatology ◽

10.1016/s0168-8278(08)60830-2 ◽

2008 ◽

Vol 48 ◽

pp. S310 ◽

Author(s):

K.R. Reddy ◽

D. Messinger ◽

M. Popescu ◽

S.J. Hadziyannis

Keyword(s):

Prognostic Factors ◽

Sustained Virological Response ◽

Virological Response ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Download Full-text

Su1053 Virological Response in Treatment-Naïve Patients With Chronic HCV Genotype-1 Infection Receiving Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin Is Unaffected by Ribavirin Dose Reduction

Gastroenterology ◽

10.1016/s0016-5085(14)63544-7 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-975-S-976 ◽

Author(s):

Tarik Asselah ◽

Donald M. Jensen ◽

Graham Foster ◽

Mark Sulkowski ◽

Denis Ouzan ◽

...

Keyword(s):

Dose Reduction ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Α ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Download Full-text

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION

Journal of Hepatology ◽

10.1016/s0168-8278(14)60886-2 ◽

2014 ◽

Vol 60 (1) ◽

pp. S311

Author(s):

T. Asselah ◽

D.M. Jensen ◽

G.R. Foster ◽

M.S. Sulkowski ◽

D. Ouzan ◽

...

Keyword(s):

Dose Reduction ◽

Virological Response ◽

Pegylated Interferon ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Download Full-text

258 ASSOCIATION OF SERUM INTERFERON-GAMMA INDUCIBLE PROTEIN 10 (IP-10) LEVELS WITH VIROLOGICAL RESPONSE TO PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN THERAPY FOR HCV GENOTYPE 1 INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(10)60260-7 ◽

2010 ◽

Vol 52 ◽

pp. S108-S109

Author(s):

M. Fukuda ◽

H. Yatsuhashi ◽

I. Takahara ◽

T. Murata ◽

S. Hashimoto ◽

...

Keyword(s):

Interferon Gamma ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Hcv Genotype ◽

Pegylated Interferon Alfa ◽

Inducible Protein ◽

Download Full-text

Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks

Intervirology ◽

10.1159/000252785 ◽

2010 ◽

Vol 53 (1) ◽

pp. 55-59 ◽

Author(s):

Taisuke Ueda ◽

Hobyung Chung ◽

Masatoshi Kudo ◽

Emi Ishikawa ◽

Sousuke Hayaishi ◽

...

Keyword(s):

Virological Response ◽

High Viral Load ◽

Hcv Genotype ◽

Download Full-text

P777 DOSE-DEPENDENT PHARMACOKINETICS FOR MK-5172 25 mg, 50 mg, AND 100 mg ONCE-DAILY FOR 12 WEEKS IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(14)60938-7 ◽

2014 ◽

Vol 60 (1) ◽

pp. S329 ◽

Author(s):

L. Caro ◽

J. Talaty ◽

M. Morrison ◽

S. Zhang ◽

Z. Guo ◽

...

Keyword(s):

Hcv Genotype ◽

Treatment Naïve ◽

Cirrhotic Patients ◽

Hcv Genotype 1 ◽

Download Full-text